Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash & Current Investments (2020 - 2025)

Biofrontera (BFRI) has 6 years of Cash & Current Investments data on record, last reported at $3.4 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 17.85% year-over-year to $3.4 million; the TTM value through Sep 2025 reached $3.4 million, up 17.85%, while the annual FY2024 figure was $5.9 million, 316.05% up from the prior year.
  • Cash & Current Investments reached $3.4 million in Q3 2025 per BFRI's latest filing, down from $7.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $31.9 million in Q2 2022 and bottomed at $1.4 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $11.4 million, with a median of $6.3 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: surged 1502.56% in 2022, then plummeted 94.88% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $24.5 million in 2021, then increased by 13.29% to $27.8 million in 2022, then tumbled by 94.88% to $1.4 million in 2023, then soared by 316.05% to $5.9 million in 2024, then plummeted by 42.03% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $3.4 million in Q3 2025, $7.2 million in Q2 2025, and $1.8 million in Q1 2025.